Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)
Hong Kong · Delayed Price · Currency is HKD 37.50
+1.54 (4.28%)
Jul 3, 2026, 4:08 PM HKT
HKG:2335 Statistics
Total Valuation
HKG:2335 has a market cap or net worth of HKD 12.44 billion. The enterprise value is 13.54 billion.
| Market Cap | 12.44B |
| Enterprise Value | 13.54B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2335 has 331.74 million shares outstanding.
| Current Share Class | 280.07M |
| Shares Outstanding | 331.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 30.87% |
| Owned by Institutions (%) | 17.90% |
| Float | 98.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -11.65 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.98
| Current Ratio | 0.98 |
| Quick Ratio | 0.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.76 |
| Interest Coverage | -2.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -33.17% |
| Return on Invested Capital (ROIC) | -42.61% |
| Return on Capital Employed (ROCE) | -236.08% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -363,971 |
| Employee Count | 558 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 2,463,742 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -170.90M |
| Pretax Income | -205.77M |
| Net Income | -203.10M |
| EBITDA | -167.05M |
| EBIT | -170.90M |
| Earnings Per Share (EPS) | -0.84 |
Balance Sheet
The company has 262.70 million in cash and 1.35 billion in debt, with a net cash position of -1.08 billion or -3.26 per share.
| Cash & Cash Equivalents | 262.70M |
| Total Debt | 1.35B |
| Net Cash | -1.08B |
| Net Cash Per Share | -3.26 |
| Equity (Book Value) | -1.07B |
| Book Value Per Share | -3.95 |
| Working Capital | -4.68M |
Cash Flow
In the last 12 months, operating cash flow was -152.60 million and capital expenditures -977,047, giving a free cash flow of -153.58 million.
| Operating Cash Flow | -152.60M |
| Capital Expenditures | -977,047 |
| Depreciation & Amortization | 4.00M |
| Net Borrowing | 209,096 |
| Free Cash Flow | -153.58M |
| FCF Per Share | -0.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:2335 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.63% |
| FCF Yield | -1.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |